Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2012
10/18/2012US20120263668 Gel composition
10/18/2012US20120263648 Rna nanoparticles and nanotubes
10/18/2012US20120263644 Treatment and diagnosis of inflammatory disorders and hiv
10/18/2012CA2833313A1 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833301A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833255A1 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833023A1 System and method for multiphasic release of growth factors
10/18/2012CA2832910A1 Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
10/18/2012CA2832467A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/17/2012EP2511262A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride
10/17/2012EP2510940A1 Use of cyr61 protein for preparing medicine
10/17/2012EP2510927A2 Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
10/17/2012EP2509999A1 Anti-inflammatory agents directed against citrullinated epitopes
10/17/2012EP2509975A1 Benzimidazole inhibitors of leukotriene production
10/17/2012EP2509943A1 2-methylene-19,26-nor-(20s)-l&-hydroxyvitamin d3
10/17/2012EP2509612A1 Methods and compositions for bone and cartilage repair
10/17/2012EP2509607A1 Glycosaminoglycan mixtures
10/17/2012EP2509598A1 N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741286A Anti human RANKL monoclonal antibodies developed by PAE technology and uses thereof
10/17/2012CN102741276A Synthetic myostatin peptide antagonists
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102740852A N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation
10/17/2012CN102740844A Combination of droloxifene and clopidogrel
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102732410A Fatigue-resisting immunity-enhancing healthcare wine and method for preparing same
10/17/2012CN102731654A High affinity antibodies against hmgb1 and methods of use thereof
10/17/2012CN102731499A Lactam compounds and their use as pharmaceuticals
10/17/2012CN102731430A Novel febuxostat crystal form, its preparation method and application thereof
10/17/2012CN102731379A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
10/17/2012CN102731344A Hydrazine nitrile cathepsin inhibitors with different P<3> structures, and application thereof
10/17/2012CN102727856A Volatile oil for treating arthralgia and injuries of tendons and preparation method of volatile oil
10/17/2012CN102727811A Pharmaceutical composition for treating rheumatoid arthritis
10/17/2012CN102727789A Chinese herbal medicine composition for treating lumbar intervertebral disc herniation
10/17/2012CN102727753A Traditional Chinese medicine composition used for treating gout, and preparation method and application thereof
10/17/2012CN102727752A Application of Wu Hu Dan capsules in preparing medicine used for treating gout
10/17/2012CN102727728A Resurgent traditional Chinese herbal preparation
10/17/2012CN102727719A External application Chinese herbal for treating protruded disc, slipped disk, prolapsed disk and hyperosteogeny
10/17/2012CN102727699A Externally used drug for treating rheumatic arthritis
10/17/2012CN102727697A Traditional Chinese medicine composition for treating bone fracture, preparation method and mass detection method of traditional Chinese medicine composition
10/17/2012CN102727679A Medicine for treating osteoporosis and its preparation method
10/17/2012CN102727647A A health care formula for foot bath
10/17/2012CN102727632A Traditional Chinese medicinal capsule for treating cervical spondylosis
10/17/2012CN102727601A External patch for treating prolapse of lumbar intervertebral disc
10/17/2012CN102727558A Tripterygium Hypoglaucum Hutch root extract, and bi-layer extended release tablet and application thereof
10/17/2012CN102727487A Novel application of 8-methoxsalen to prevention and treatment of osteoporosis for post-menopause women
10/17/2012CN102727482A Daidzein-hydroxypropyl-beta-cyclodextrin clathrate and its preparation method
10/17/2012CN102727476A Application of retinoic acid and its derivatives in preparation of drugs preventing and treating osteoporosis
10/17/2012CN102727473A Pharmaceutical usage of N,N'-1,2-ethanediylbis[N-[(2,3-dihydroxyphenyl) methyl]]-glycine and derivatives thereof
10/17/2012CN102727454A Evodiamine dispersion tablets and preparation method thereof
10/17/2012CN102727424A Sodium hyaluronate gel injection for bone joint cavity and preparation method thereof
10/17/2012CN102727370A Traditional Chinese herbal physical therapy ball for treating cervical spondylosis
10/17/2012CN102726683A Equol-containing fermented soybean hypocotyl material
10/17/2012CN102232964B Medicine for treating urinary stones and hyperuricemia
10/17/2012CN102138986B Medicated bath material for treating rheumatism and gout and preparation method thereof
10/17/2012CN101991852B Application of miR-494 inhibitor in preparing preparation for resisting bone calcium loss and promoting bone formation
10/17/2012CN101851237B spiro compounds, method for preparing same and application thereof
10/17/2012CN101732400B Active extractive combination of himalayan teasel roots and astragalus roots and application thereof in medicine industry
10/17/2012CN101412692B 1-(3-amino propyl) piperidine-4-aminoamide compounds, and pharmaceutical composition, preparation and use thereof
10/16/2012US8288539 Dipeptidyl peptidase inhibitors
10/16/2012US8288537 Caspase inhibitors and uses thereof
10/16/2012US8288536 Kinase inhibitors
10/16/2012US8288368 inhibitors of the C5a induced chemotaxis; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, rheumatoid arthritis and in the prevention and the treatment of injury caused by ischemia and reperfusion
10/16/2012US8288344 Glass particles in aqueous carrier mixture containing glycerol and polyoxyethylene glycol
10/16/2012US8287873 Vascular endothelial cell growth factor antagonists and uses thereof
10/16/2012US8287863 Method for treating myeloma utilizing an expression enhancer for HM1.24 antigen
10/16/2012CA2648594C Solid oral dosage form containing an enhancer
10/16/2012CA2563895C Disalt inhibitors of il-12 production
10/16/2012CA2485681C Ccr9 inhibitors and methods of use thereof
10/16/2012CA2466773C Inhibitor oligonucleotides and their use for specific repression of a gene
10/16/2012CA2356257C Insulin-like growth factor (igf) i mutant variants
10/11/2012WO2012139069A2 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
10/11/2012WO2012136121A1 Amino phenylpropanoid compound and use thereof for preparing immunosuppressant
10/11/2012WO2012074330A3 Fusion peptide comprising dhfas-1 domain and mmp substrate and use thereof for preventing and treating rheumatoid arthritis
10/11/2012US20120259151 Pyridopyrazine derivatives and their use
10/11/2012US20120259013 Liquid dosage forms of isotretinoin
10/11/2012US20120259002 Molecule for treating an inflammatory disorder
10/11/2012US20120258986 Olefin containing nuclear transport modulators and uses thereof
10/11/2012US20120258983 Pharmaceutical Composition and Administrations Thereof
10/11/2012US20120258982 Adamantyl compounds
10/11/2012US20120258967 Pi3 kinase inhibitors and uses thereof
10/11/2012US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258954 ArylSulfonamide Based Matrix Metalloprotease Inhibitors
10/11/2012US20120258952 Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors
10/11/2012US20120258938 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof
10/11/2012US20120258931 Regimens for Intra-Articular Viscosupplementation
10/11/2012US20120258930 The Improvement of Gastrointestinal Health, Immunity and Performance by Dietary Intervention
10/11/2012US20120258924 Method of modulating stress-activated protein kinase system
10/11/2012US20120258919 Collagen peptide, dipeptide and malady inhibitor
10/11/2012US20120258917 Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
10/11/2012US20120258911 Phenylalkylcarboxylic acid delivery agents
10/11/2012US20120258905 Vitamin receptor drug delivery conjugates for treating inflammation
10/11/2012US20120258186 Method of treating areas of osteoarthritis in animals and human beings with milkweed seed oil
10/11/2012US20120258184 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and food or beverage
10/11/2012US20120258178 Demineralized bone matrix compositions and methods
10/11/2012US20120258160 Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds
10/11/2012US20120258148 Endosseous implant
10/11/2012US20120258147 Method for inhibiting angiogenesis
10/11/2012US20120258135 Immunogenic anti-inflammatory compositions
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 820